Literature DB >> 15378007

Stat3 upregulates MEK5 expression in human breast cancer cells.

Hui Song1, Xiaohong Jin, Jiayuh Lin.   

Abstract

The constitutive activation of signal transducer and activator of transcription 3 (Stat3) is frequently detected in breast cancer cell lines but not in normal breast epithelial cells. Stat3 has been classified as an oncogene, because constitutively active Stat3 can mediate oncogenic transformation in cultured cells and tumor formation in nude mice. Since Stat3 appears to play an important role in breast cancer, it is of interest to investigate Stat3-regulated genes and elucidate Stat3-mediated oncogenesis. In this study, we investigated the Stat3-regulated genes in human breast epithelial cells. Upon overexpression of Stat3-C, a constitutively active Stat3 form, in nonmalignant telomerase immortalized breast (TERT) cells, the total mRNA was extracted and subjected to Affymetrix microarray analysis. Our results showed that mitogen-activated protein kinase kinase 5 (MEK5) was markedly induced (more than 22-fold increase, P<0.001) by Stat3-C expression. RT-PCR result also demonstrated that MEK5 mRNA was significantly induced by Stat3-C in TERT cells. The upregulation of MEK5 by Stat3-C was further confirmed by Western blot in MCF10A breast epithelial cells. Furthermore, in MDA-MB-435s breast carcinoma cells, which express high levels of activated Stat3 and MEK5, MEK5 protein was significantly reduced by using Stat3 short interfering RNA. The reduction of MEK5 was consistent with Stat3 knockdown in this breast carcinoma cell line. We also investigated MEK5 expression in different breast carcinoma cell lines and breast cancer tissues using tissue array analysis. Compared with nonmalignant breast epithelial cells or normal tissues without constitutively active Stat3 signaling, MEK5 protein levels are remarkably higher in breast carcinoma cell lines and cancer tissues with constitutively activated Stat3. Taken together, our findings suggest that constitutively active Stat3 upregulates MEK5 in the breast epithelial cells. MEK5 may be one of the Stat3-regulated genes and plays its essential roles in oncogenesis mediated by aberrantly activated Stat3 signaling in breast carcinomatosis and malignancies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378007     DOI: 10.1038/sj.onc.1208026

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

2.  Mitogen/extracellular signal-regulated kinase kinase-5 promoter region polymorphisms affect the risk of sporadic colorectal cancer in a southern Chinese population.

Authors:  Dechang Diao; Lei Wang; Jun-Xiao Zhang; Dianke Chen; Huanliang Liu; Yisheng Wei; Jiachun Lu; Junsheng Peng; Jianping Wang
Journal:  DNA Cell Biol       Date:  2011-08-23       Impact factor: 3.311

3.  ERK5 signalling pathway is essential for fluid shear stress-induced COX-2 gene expression in MC3T3-E1 osteoblast.

Authors:  Jin Jiang; Liang-gong Zhao; Yuan-jun Teng; Shao-long Chen; Li-ping An; Jing-ling Ma; Jing Wang; Ya-yi Xia
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

4.  Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response.

Authors:  Xu Zhang; Tapan Maity; Manoj K Kashyap; Mukesh Bansal; Abhilash Venugopalan; Sahib Singh; Shivangi Awasthi; Arivusudar Marimuthu; Harrys Kishore Charles Jacob; Natalya Belkina; Stephanie Pitts; Constance M Cultraro; Shaojian Gao; Guldal Kirkali; Romi Biswas; Raghothama Chaerkady; Andrea Califano; Akhilesh Pandey; Udayan Guha
Journal:  Mol Cell Proteomics       Date:  2017-03-22       Impact factor: 5.911

5.  Targeting the BMK1 MAP kinase pathway in cancer therapy.

Authors:  Qingkai Yang; Jiing-Dwan Lee
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

Review 6.  MEK5/ERK5 pathway: the first fifteen years.

Authors:  Barbara A Drew; Matthew E Burow; Barbara S Beckman
Journal:  Biochim Biophys Acta       Date:  2011-10-13

7.  Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.

Authors:  Arti Shukla; Jill M Miller; Christopher Cason; Mutlay Sayan; Maximilian B MacPherson; Stacie L Beuschel; Jedd Hillegass; Pamela M Vacek; Harvey I Pass; Brooke T Mossman
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

8.  An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.

Authors:  Maria Elena Bravo-Adame; Rosario Vera-Estrella; Bronwyn J Barkla; Cecilia Martínez-Campos; Angel Flores-Alcantar; Jose Pablo Ocelotl-Oviedo; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

9.  ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Danilenko; George P Studzinski
Journal:  J Cell Physiol       Date:  2014-07       Impact factor: 6.384

10.  Discovery of pathway biomarkers from coupled proteomics and systems biology methods.

Authors:  Fan Zhang; Jake Y Chen
Journal:  BMC Genomics       Date:  2010-11-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.